Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Revenue | $607 | $568 | $506 | $181 |
| % Growth | 6.8% | 12.3% | 179% | – |
| Cost of Goods Sold | $126 | $225 | $117 | $53 |
| Gross Profit | $481 | $343 | $388 | $129 |
| % Margin | 79.2% | 60.4% | 76.8% | 71% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $9,145 | $11,983 | $5,954 | $3,485 |
| SG&A Expenses | $9,145 | $11,983 | $5,954 | $3,485 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $10 |
| Operating Expenses | $9,221 | $11,983 | $5,954 | $3,485 |
| Operating Income | -$8,979 | -$11,640 | -$5,566 | -$3,357 |
| % Margin | -1,479.8% | -2,049.6% | -1,100.9% | -1,852.2% |
| Other Income/Exp. Net | -$5,260 | -$1,102 | $94 | $187 |
| Pre-Tax Income | -$30,908 | -$12,742 | -$5,472 | -$3,170 |
| Tax Expense | $16,707 | $7 | $121 | $41 |
| Net Income | -$30,908 | -$12,749 | -$5,593 | -$3,211 |
| % Margin | -5,093.6% | -2,245% | -1,106.2% | -1,772.1% |
| EPS | -0.5 | -0.22 | -0.1 | -3.79 |
| % Growth | -127.3% | -120% | 97.4% | – |
| EPS Diluted | -0.005 | -0.002 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 61,515 | 58,812 | 53,696 | 847 |
| Weighted Avg Shares Out Dil | 6,151,500 | 5,881,207 | 5,369,618 | 2,562,276 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $16,907 | $1,095 | $121 | $31 |
| Depreciation & Amortization | $208 | $191 | $186 | $108 |
| EBITDA | -$8,732 | -$11,449 | -$5,380 | -$3,249 |
| % Margin | -1,439.1% | -2,016% | -1,064.1% | -1,792.8% |